Learn To Invest
Stocks Special Reports LICs Credit Funds ETFs Tools SMSFs
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features SMSFs Learn

Company News Summary

CSL Provides an Update Regarding Vifor Pharma Acquisition

12 May 2022  |  09:34:00  |  Associate analysts  |  Increase  |  Decrease  |  

Original announcement: Vifor update ASX Announcement for lodgement

CSL advised that it is expected to be in a position to close the acquisition of Vifor Pharma AG by June 2022. It expects the regulatory approval process to take a few more months. It remains confident of completing its acquisition of Vifor Pharma AG and looks forward to expanding its presence in the rapidly growing nephrology market, as well as leveraging the companies' combined expertise to continue to deliver innovative solutions to rare and serious illness.

Please click here for full details

See more ASX300 News Announcements